Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

Defeat Diabetes
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708


Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

MannKind Inhaled Insulin Matches Injections -Study
Posted: Thursday, September 21, 2006
An inhaled insulin being developed by MannKind Corp produces comparable improvements in blood sugar control to rapid-acting insulin analog (RAA) given by injection, researchers said on Saturday.

Optimizing Control in Diabetes (OPTIMIZE) Survey Urges Action NOW!
Posted: Thursday, September 21, 2006
Diabetes experts have warned that urgent action needs to be taken to drastically improve the management of diabetes to prevent a potentially devastating and costly global burden.

Pioglitazone Demonstrates Significant Improvements in Cardiovascular Outcomes
Posted: Thursday, September 21, 2006
Actos® (pioglitazone HCl), an oral antidiabetic medication, demonstrated significant cardiovascular benefits in reducing the risk of heart attack and/or stroke and acute coronary syndrome in patients with type 2 diabetes.

New Positive Data On Levemir, NovoRapid
Posted: Thursday, September 21, 2006
Levemir improves glucose control without weight gain and hypoglycemia.

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 2- Ramipril Arm)
Posted: Thursday, September 21, 2006
The Dream Study also found that the ACE-inhibitor Altace (ramipril) does not prevent type 2 diabetes in patients with impaired glucose metabolism.

A Mid-Summer’s Night DREAM: Diabetes Prevention (Part 1-Rosiglitazone Arm)
Posted: Thursday, September 21, 2006
The results of a major study released: The Dream Study (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) with over 5000 patients Rosiglitazone reduced the risk of developing type 2 diabetes by 62 percent (p<0.0001) relative to placebo among people at high risk of developing type 2 diabetes.

Significant Glucose-Lowering Efficacy Of JANUVIA™ in Phase III Study
Posted: Thursday, September 21, 2006
New data presented for the first time at the 42nd annual meeting of the European Association for the Study of Diabetes (EASD) in Copenhagen demonstrated a mean reduction in A1C of 2.1% from a mean baseline A1C of 8.8% and a reduction of 2.9% for those with a mean A1c of 11.2%.

New Hypertension Pills Cut Diabetes Risk by A Third
Posted: Thursday, September 21, 2006
Researchers have reported that patients given a specific combination of new blood pressure drugs are one-third less likely to develop diabetes than those on older pills.

Galvus® Demonstrates Powerful Blood Sugar Reductions In Phase III Studies
Posted: Thursday, September 21, 2006
Galvus dropped A1c by 1.8% without weight gain.

Steroids Trial Beats Diabetes Blindness
Posted: Wednesday, September 13, 2006
Australian research has proven the effectiveness of a steroid treatment for a type of diabetic blindness.

Page 105 of 120
 |<   <<   <  100  |  101  |  102  |  103  |  104  |  105  |  106  |  107  |  108  |  109  |  110  >   >>   >| 

Join us on Facebook

Send your unopened, unexpired diabetes testing supplies to:

Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708


DDF advertisement

 Friendly Banner

Friendly Banner
Analyze nutrition content by portion
DDF advertisement